Literature DB >> 23403424

Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms.

Dorothy F Newton1, Sandra Macfarlane, George T Macfarlane.   

Abstract

The composition and metabolic activities of the human colonic microbiota are modulated by a number of external factors, including diet and antibiotic therapy. Changes in the structure and metabolism of the gut microbiota may have long-term consequences for host health. The large intestine harbors a complex microbial ecosystem comprising several hundreds of different bacterial species, which complicates investigations on intestinal physiology and ecology. To facilitate such studies, a highly simplified microbiota consisting of 14 anaerobic and facultatively anaerobic organisms (Bacteroides thetaiotaomicron, Bacteroides vulgatus, Bifidobacterium longum, Bifidobacterium infantis, Bifidobacterium pseudolongum, Bifidobacterium adolescentis, Clostridium butyricum, C. perfringens, C. bifermentans, C. innocuum, Escherichia coli, Enterococcus faecalis, Enterococcus faecium, Lactobacillus acidophilus) was used in this investigation. Ampicillin [9.2 μg (ml culture)(-1)] was added to two chemostats operated at different dilution rates (D; 0.10 h(-1) and 0.21 h(-1)), and metronidazole [76.9 μg (ml culture)(-1)] was added to a third vessel (D = 0.21 h(-1)). Perturbations in bacterial physiology and metabolism were sampled over a 48-h period. Lactobacillus acidophilus and C. bifermentans populations did not establish in the fermentors under the imposed growth conditions. Ampicillin resulted in substantial reductions in bacteroides and C. perfringens populations at both dilution rates. Metronidazole strongly affected bacteroides communities but had no effect on bifidobacterial communities. The bacteriostatic effect of ampicillin on bifidobacterial species was growth rate dependent. Several metabolic activities were affected by antibiotic addition, including fermentation product formation and enzyme synthesis. The growth of antibiotic-resistant bifidobacteria in the large bowel may enable them to occupy ecological niches left vacant after antibiotic administration, preventing colonization by pathogenic species.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23403424      PMCID: PMC3632929          DOI: 10.1128/AAC.00079-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  50 in total

Review 1.  The gut flora as a forgotten organ.

Authors:  Ann M O'Hara; Fergus Shanahan
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

2.  Influence of peroral antibiotics upon the biotransformatory activity of the intestinal microflora in healthy subjects.

Authors:  T Midtvedt; B Carlstedt-Duke; T Høverstad; E Lingaas; E Norin; H Saxerholt; M Steinbakk
Journal:  Eur J Clin Invest       Date:  1986-02       Impact factor: 4.686

Review 3.  Metronidazole.

Authors:  B E Scully
Journal:  Med Clin North Am       Date:  1988-05       Impact factor: 5.456

Review 4.  Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections.

Authors:  C E Nord; L Kager; A Heimdahl
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

5.  The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes.

Authors:  E Perez-Reyes; B Kalyanaraman; R P Mason
Journal:  Mol Pharmacol       Date:  1980-03       Impact factor: 4.436

6.  Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system.

Authors:  Sandra Macfarlane; Emma J Woodmansey; George T Macfarlane
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

7.  Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis.

Authors:  M Wlodarska; B Willing; K M Keeney; A Menendez; K S Bergstrom; N Gill; S L Russell; B A Vallance; B B Finlay
Journal:  Infect Immun       Date:  2011-02-14       Impact factor: 3.441

8.  Mode of action of metronidazole on anaerobic bacteria and protozoa.

Authors:  M Müller
Journal:  Surgery       Date:  1983-01       Impact factor: 3.982

9.  Antibiotic prophylaxis with cefoxitin in colorectal surgery: effect on the colon microflora and septic complications--a clinical model for prediction of the benefit and risks in using a new antibiotic in prophylaxis.

Authors:  L Kager; I Ljungdahl; A S Malmborg; C E Nord; R Pieper; P Dahlgren
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

10.  Human fecal flora: the normal flora of 20 Japanese-Hawaiians.

Authors:  W E Moore; L V Holdeman
Journal:  Appl Microbiol       Date:  1974-05
View more
  13 in total

1.  Clinical chorioamnionitis at term VIII: a rapid MMP-8 test for the identification of intra-amniotic inflammation.

Authors:  Noppadol Chaiyasit; Roberto Romero; Piya Chaemsaithong; Nikolina Docheva; Gaurav Bhatti; Juan Pedro Kusanovic; Zhong Dong; Lami Yeo; Percy Pacora; Sonia S Hassan; Offer Erez
Journal:  J Perinat Med       Date:  2017-07-26       Impact factor: 1.901

Review 2.  Synthetic ecology of the human gut microbiota.

Authors:  Gino Vrancken; Ann C Gregory; Geert R B Huys; Karoline Faust; Jeroen Raes
Journal:  Nat Rev Microbiol       Date:  2019-10-02       Impact factor: 60.633

3.  Strain-level analysis of gut-resident pro-inflammatory viridans group Streptococci suppressed by long-term cotrimoxazole prophylaxis among HIV-positive children in Zimbabwe.

Authors:  Ethan K Gough; Claire D Bourke; Chipo Berejena; Annie Shonhai; Mutsa Bwakura-Dangarembizi; Andrew J Prendergast; Amee R Manges
Journal:  Gut Microbes       Date:  2020-02-05

4.  In vitro fermentation test bed for evaluation of engineered probiotics in polymicrobial communities.

Authors:  Steven Arcidiacono; Amy M Ehrenworth Breedon; Michael S Goodson; Laurel A Doherty; Wanda Lyon; Grace Jimenez; Ida G Pantoja-Feliciano; Jason W Soares
Journal:  J Biol Methods       Date:  2021-05-26

5.  Clostridium difficile colonization and antibiotics response in PolyFermS continuous model mimicking elderly intestinal fermentation.

Authors:  Sophie Fehlbaum; Christophe Chassard; Sophie Annick Poeker; Muriel Derrien; Candice Fourmestraux; Christophe Lacroix
Journal:  Gut Pathog       Date:  2016-12-01       Impact factor: 4.181

6.  Antibiotic Treatments for Clostridium difficile Infection Are Associated with Distinct Bacterial and Fungal Community Structures.

Authors:  Regina Lamendella; Justin R Wright; Jada Hackman; Christopher McLimans; David R Toole; William Bernard Rubio; Rebecca Drucker; Hoi Tong Wong; Kate Sabey; John P Hegarty; David B Stewart
Journal:  mSphere       Date:  2018-01-10       Impact factor: 4.389

7.  The In-Feed Antibiotic Carbadox Induces Phage Gene Transcription in the Swine Gut Microbiome.

Authors:  Timothy A Johnson; Torey Looft; Andrew J Severin; Darrell O Bayles; Daniel J Nasko; K Eric Wommack; Adina Howe; Heather K Allen
Journal:  mBio       Date:  2017-08-08       Impact factor: 7.867

8.  Integrated culturing, modeling and transcriptomics uncovers complex interactions and emergent behavior in a three-species synthetic gut community.

Authors:  Kevin D'hoe; Stefan Vet; Karoline Faust; Luc De Vuyst; Jeroen Raes; Frédéric Moens; Gwen Falony; Didier Gonze; Verónica Lloréns-Rico; Lendert Gelens; Jan Danckaert
Journal:  Elife       Date:  2018-10-16       Impact factor: 8.140

Review 9.  Colonization Resistance of the Gut Microbiota against Clostridium difficile.

Authors:  Ana Elena Pérez-Cobas; Andrés Moya; María José Gosalbes; Amparo Latorre
Journal:  Antibiotics (Basel)       Date:  2015-08-07

10.  Changes in Composition and Function of Human Intestinal Microbiota Exposed to Chlorpyrifos in Oil as Assessed by the SHIME® Model.

Authors:  Julie Reygner; Claire Joly Condette; Aurélia Bruneau; Stéphane Delanaud; Larbi Rhazi; Flore Depeint; Latifa Abdennebi-Najar; Veronique Bach; Camille Mayeur; Hafida Khorsi-Cauet
Journal:  Int J Environ Res Public Health       Date:  2016-11-04       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.